Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11865 | 948 | 37.6 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
427 | 3 | JOURNAL OF THE INSTITUTE OF BREWING//KERATINASE//CYSTATIN | 27946 |
1744 | 2 | CATHEPSIN//CATHEPSIN K//CATHEPSIN B | 6503 |
11865 | 1 | CATHEPSIN K//PYCNODYSOSTOSIS//CATHEPSIN K INHIBITOR | 948 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CATHEPSIN K | authKW | 3862875 | 23% | 56% | 216 |
2 | PYCNODYSOSTOSIS | authKW | 1400162 | 5% | 91% | 48 |
3 | CATHEPSIN K INHIBITOR | authKW | 942088 | 4% | 75% | 39 |
4 | ODANACATIB | authKW | 792180 | 4% | 72% | 34 |
5 | CATHEPSIN | authKW | 429601 | 11% | 12% | 107 |
6 | ONO 5334 | authKW | 354297 | 1% | 100% | 11 |
7 | CATHEPSIN S INHIBITOR | authKW | 289879 | 1% | 100% | 9 |
8 | PYKNODYSOSTOSIS | authKW | 229038 | 1% | 89% | 8 |
9 | DISCOVERY COMPUTAT ANALYT STRUCT SCI | address | 225462 | 1% | 100% | 7 |
10 | WORLD WIDE PHYS PROPERTIES | address | 206133 | 1% | 80% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 3065 | 17% | 0% | 164 |
2 | Endocrinology & Metabolism | 1682 | 17% | 0% | 162 |
3 | Chemistry, Organic | 346 | 10% | 0% | 96 |
4 | Biochemistry & Molecular Biology | 317 | 19% | 0% | 181 |
5 | Rheumatology | 237 | 3% | 0% | 30 |
6 | Dentistry, Oral Surgery & Medicine | 150 | 4% | 0% | 35 |
7 | Peripheral Vascular Diseases | 150 | 4% | 0% | 42 |
8 | Pharmacology & Pharmacy | 133 | 9% | 0% | 90 |
9 | Medicine, Research & Experimental | 81 | 5% | 0% | 44 |
10 | Cell Biology | 64 | 6% | 0% | 60 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DISCOVERY COMPUTAT ANALYT STRUCT SCI | 225462 | 1% | 100% | 7 |
2 | WORLD WIDE PHYS PROPERTIES | 206133 | 1% | 80% | 8 |
3 | GENE EXP S PROT PURIFICAT | 193253 | 1% | 100% | 6 |
4 | SECT OXIDAT ST S INFLAMMAT | 96626 | 0% | 100% | 3 |
5 | CLIN DEV PLANNING | 89464 | 1% | 56% | 5 |
6 | PHYS STRUCT CHEM | 70254 | 1% | 18% | 12 |
7 | BONE CARTILAGE BIOL | 66360 | 1% | 16% | 13 |
8 | CLIN CELL BIOLLILLEBAELT HOSP | 64418 | 0% | 100% | 2 |
9 | LILLEBAELT VEJLE HOSP | 64418 | 0% | 100% | 2 |
10 | SHANGHAI ENDOCRINE METAB | 64418 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BONE | 12079 | 5% | 1% | 50 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 7323 | 8% | 0% | 76 |
3 | JOURNAL OF BONE AND MINERAL RESEARCH | 6958 | 4% | 1% | 38 |
4 | CALCIFIED TISSUE INTERNATIONAL | 2382 | 2% | 0% | 19 |
5 | JOURNAL OF MEDICINAL CHEMISTRY | 1895 | 4% | 0% | 36 |
6 | JOURNAL OF BONE AND MINERAL METABOLISM | 1426 | 1% | 1% | 8 |
7 | EXPERT OPINION ON THERAPEUTIC PATENTS | 1157 | 1% | 0% | 9 |
8 | BIOLOGICAL CHEMISTRY | 800 | 1% | 0% | 9 |
9 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | 684 | 1% | 0% | 7 |
10 | CURRENT OSTEOPOROSIS REPORTS | 522 | 0% | 1% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CATHEPSIN K | 3862875 | 23% | 56% | 216 | Search CATHEPSIN+K | Search CATHEPSIN+K |
2 | PYCNODYSOSTOSIS | 1400162 | 5% | 91% | 48 | Search PYCNODYSOSTOSIS | Search PYCNODYSOSTOSIS |
3 | CATHEPSIN K INHIBITOR | 942088 | 4% | 75% | 39 | Search CATHEPSIN+K+INHIBITOR | Search CATHEPSIN+K+INHIBITOR |
4 | ODANACATIB | 792180 | 4% | 72% | 34 | Search ODANACATIB | Search ODANACATIB |
5 | CATHEPSIN | 429601 | 11% | 12% | 107 | Search CATHEPSIN | Search CATHEPSIN |
6 | ONO 5334 | 354297 | 1% | 100% | 11 | Search ONO+5334 | Search ONO+5334 |
7 | CATHEPSIN S INHIBITOR | 289879 | 1% | 100% | 9 | Search CATHEPSIN+S+INHIBITOR | Search CATHEPSIN+S+INHIBITOR |
8 | PYKNODYSOSTOSIS | 229038 | 1% | 89% | 8 | Search PYKNODYSOSTOSIS | Search PYKNODYSOSTOSIS |
9 | DRYNARIAE RHIZOMA | 134202 | 1% | 83% | 5 | Search DRYNARIAE+RHIZOMA | Search DRYNARIAE+RHIZOMA |
10 | CTSK | 128831 | 1% | 67% | 6 | Search CTSK | Search CTSK |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BROMME, D , PANWAR, P , TURAN, S , (2016) CATHEPSIN K OSTEOPOROSIS TRIALS, PYCNODYSOSTOSIS AND MOUSE DEFICIENCY MODELS: COMMONALITIES AND DIFFERENCES.EXPERT OPINION ON DRUG DISCOVERY. VOL. 11. ISSUE 5. P. 457 -472 | 114 | 79% | 0 |
2 | COSTA, AG , CUSANO, NE , SILVA, BC , CREMERS, S , BILEZIKIAN, JP , (2011) CATHEPSIN K: ITS SKELETAL ACTIONS AND ROLE AS A THERAPEUTIC TARGET IN OSTEOPOROSIS.NATURE REVIEWS RHEUMATOLOGY. VOL. 7. ISSUE 8. P. 447 -456 | 67 | 84% | 84 |
3 | BROMME, D , LECAILLE, F , (2009) CATHEPSIN K INHIBITORS FOR OSTEOPOROSIS AND POTENTIAL OFF-TARGET EFFECTS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 18. ISSUE 5. P. 585-600 | 89 | 72% | 71 |
4 | WEN, X , YI, LZ , LIU, F , WEI, JH , XUE, Y , (2016) THE ROLE OF CATHEPSIN K IN ORAL AND MAXILLOFACIAL DISORDERS.ORAL DISEASES. VOL. 22. ISSUE 2. P. 109 -115 | 64 | 80% | 1 |
5 | XUE, Y , CAI, T , SHI, ST , WANG, WG , ZHANG, YL , MAO, TQ , DUAN, XH , (2011) CLINICAL AND ANIMAL RESEARCH FINDINGS IN PYCNODYSOSTOSIS AND GENE MUTATIONS OF CATHEPSIN K FROM 1996 TO 2011.ORPHANET JOURNAL OF RARE DISEASES. VOL. 6. ISSUE . P. - | 69 | 81% | 23 |
6 | NOVINEC, M , LENARCIC, B , (2013) CATHEPSIN K: A UNIQUE COLLAGENOLYTIC CYSTEINE PEPTIDASE.BIOLOGICAL CHEMISTRY. VOL. 394. ISSUE 9. P. 1163-1179 | 77 | 63% | 25 |
7 | DUONG, LT , LEUNG, AT , LANGDAHL, B , (2016) CATHEPSIN K INHIBITION: A NEW MECHANISM FOR THE TREATMENT OF OSTEOPOROSIS.CALCIFIED TISSUE INTERNATIONAL. VOL. 98. ISSUE 4. P. 381 -397 | 47 | 70% | 6 |
8 | KOMETANI, M , NONOMURA, K , TOMOO, T , NIWA, S , (2010) HURDLES IN THE DRUG DISCOVERY OF CATHEPSIN K INHIBITORS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 7. P. 733-744 | 81 | 64% | 9 |
9 | MUKHERJEE, K , CHATTOPADHYAY, N , (2016) PHARMACOLOGICAL INHIBITION OF CATHEPSIN K: A PROMISING NOVEL APPROACH FOR POSTMENOPAUSAL OSTEOPOROSIS THERAPY.BIOCHEMICAL PHARMACOLOGY. VOL. 117. ISSUE . P. 10 -19 | 57 | 70% | 1 |
10 | LECAILLE, F , BROMME, D , LALMANACH, G , (2008) BIOCHEMICAL PROPERTIES AND REGULATION OF CATHEPSIN K ACTIVITY.BIOCHIMIE. VOL. 90. ISSUE 2. P. 208 -226 | 108 | 41% | 68 |
Classes with closest relation at Level 1 |